
SanMelix Laboratories
OperatingSanMelix Laboratories, Inc.
Biotech · Hollywood, FL
Helping You Heal with Honey Our Goal is Simple, Faster and Healthier Healing
Financials
FY2017–FY2025 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
11 people
Mrs. Sabacinski is a Certified Public Accountant (CPA) and Certified Fraud Examiner(CFE) with more than 25 years of C-level management experience in the service, manufacturing, government contracting, and healthcare industries. She is an Entrepreneur and co-founded, co-owned, and operated a multi-location training organization, which was listed on the INC 500 Fastest Growing Companies.

Dr. Sabacinski is board certified and has over 30 years’ clinical experience in Foot & Ankle medicine, surgery, and limb salvage. Dr. Sabacinski performed his internship, residency and fellowship training at the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. During his residency at the Beth Israel Deaconess Medical Center and the Joslin Diabetes Center, he was specifically trained in the treatment of acute and chronic diabetic foot ulcers. Dr. Sabacinski is the inventor of multiple advanced wound care patents, including SanMelix's BEECure™ wound care dressings.

Dr. Jason Green, DO, FAOCD, FAAD, Board Certified Dermatologist, is the founder of Green Dermatology & Cosmetic Center in Deerfield Beach, Florida. Providing outstanding dermatological care, state-of-the-art procedures, cutting-edge technology, and personalized patient attention is his priority.

Mr. Constantine has forty 40 years healthcare industry experience with a strong history of advancement within the bio- technology and medical device sectors. Professional skill set includes corporate and division level leadership of product development and project management for early stage and mature organizations. Extensive experience in the areas of pharmaceuticals, tissue engineering, wound healing and skin care. Principal efforts have been the support to start-ups by developing products and FDA regulatory strategies including 510(k) applications.

Mrs. Murphy Coordinates successful product launches with large distributors such as Amazon. She received the Gold Stevie Award for Entrepreneur of the Year by the American Business Awards and the Global CEO Excellence award. She was also named a ‘Top 40 Under 40 Rising Star’.

Marie Williams has 15+ years’ experience in education and healthcare. As the Operations Manager, Marie is directly responsible for ensuring the day-to-day processes at SanMelix run efficiently, while performing customer service activities, accounts receivable, billing and payroll duties.

Through his military career as a staff surgeon at a Level I trauma center and multiple combat deployments, Dr. Peoples is the founder of Trauma Insight. He has extensive trauma experience and has developed close relationships with some of the most prominent military and civilian trauma and critical care physicians in the country.

Ed Quilty is a well accomplished senior business executive who has consistently led, built, and transformed organizations. During his career, he has been the CEO of four publicly-listed companies. Mr. Quilty currently is a Board Member and Advisor to several companies in the healthcare sector with over 25 years of Chief Executive experience in the healthcare industry – primarily in advanced wound care – with expertise in strategic planning, financing, management, and sales and marketing. Mr. Quilty has previously served as the CEO and Chairman of the Board of Derma Sciences Inc.—creator of Medihoney—(now Integra LifeSciences) for over 15 years.

FloSure Technologies was founded in 2011 by Hamid Khosrowshahi, a successful entrepreneur who has spent a career in the area of medical devices. He was the guiding hand behind the success of such products as: Exudry, Kollagen (Medifil and Skintemp), DuraGen (dural graft matrix), NeuraGen (nerve guide) and most recently the PRO series of negative pressure wound therapy pumps by Prospera.
Show 2 more peopleShow fewer


Samuel Hammer is the Managing Shareholder for Hammer Navarro and Associates, PA. Sam is a Certified Public Accountant (CPA) and Certified Chartered Global Management Accountant (CGMA) with more than 30 years of healthcare experience serving as a C-Suite Operating Executive, Board of Director and Advisor to Physicians, Employers, Payors, Hospitals, Physician Groups, Law Firms, Manufacturers and Government.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 6 of 7 annual reports (FY2019–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 25 filings on EDGAR- Form C-TRMar 4, 20260001768911-26-000001EDGAR
- Form C-ARMar 14, 20250001654954-25-002776EDGAR
- Form C-ARMar 28, 20240001654954-24-003806EDGAR
- Form C-ARMar 30, 20230001665160-23-000503EDGAR
- Form C-ARMay 2, 20220001665160-22-001438EDGAR
- Form C-UJan 13, 20220001665160-22-000086EDGAR
- Form C-AR/ADec 30, 20210001665160-21-002425EDGAR
- Form C-UDec 7, 20210001665160-21-002153EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.